Smith & Wesson (SWBI)

American firearms manufacturer Smith & Wesson (NASDAQ:SWBI) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 17.1% year on year to $135.7 million. Its non-GAAP profit of $0.08 per share was 60% above analysts’ consensus estimates.

Company Overview

With a history dating back to 1852, Smith & Wesson (NASDAQ:SWBI) is a firearms manufacturer known for its handguns and rifles.

The Consumer Discretionary sector, by definition, is made up of companies selling non-essential goods and services. When economic conditions deteriorate or tastes shift, consumers can easily cut back or eliminate these purchases. For long-term investors with five-year holding periods, this creates a structural challenge: the sector is inherently hit-driven, with low switching costs and fickle customers. As a result, only a handful of companies can reliably grow demand and compound earnings over long periods, which is why our bar is high and High Quality ratings are rare.

Leisure products companies manufacture recreational goods such as bicycles, marine vessels, fitness equipment, camping gear, and musical instruments. Tailwinds include heightened outdoor-activity participation, health-and-wellness awareness, and periodic innovation cycles that drive trade-up purchases. Headwinds are pronounced: demand is highly discretionary and sensitive to economic cycles—consumers readily defer big-ticket leisure purchases during downturns. Post-pandemic normalization has created excess channel inventory after demand surged then retreated. Raw-material and shipping cost inflation squeezes margins, while competition from low-cost imports and a fragmented market make pricing power elusive for most players.

Competitors in the firearms market include Sturm, Ruger & Company (NYSE:RGR), Vista Outdoor (NYSE:VSTO), and American Outdoor Brands (NASDAQ:AOUT).

Reviewing a company’s long-term sales performance reveals insights into its quality. Any business can put up a good quarter or two, but many enduring ones grow for years. Smith & Wesson struggled to consistently generate demand over the last five years as its sales dropped at a 12.2% annual rate. This was below our standards and suggests it’s a low quality business.

Long-term growth is the most important, but within consumer discretionary, product cycles are short and revenue can be hit-driven due to rapidly changing trends and consumer preferences. Smith & Wesson’s annualized revenue declines of 3.4% over the last two years suggest its demand continued shrinking.

This quarter, Smith & Wesson reported year-on-year revenue growth of 17.1%, and its $135.7 million of revenue exceeded Wall Street’s estimates by 8.1%.

Looking ahead, sell-side analysts expect revenue to decline by 1.5% over the next 12 months. Although this projection is better than its two-year trend, it’s tough to feel optimistic about a company facing demand difficulties.

Smith & Wesson’s operating margin has shrunk over the last 12 months and averaged 6% over the last two years. The company’s profitability was mediocre for a consumer discretionary business and shows it couldn’t pass its higher operating expenses onto its customers.

In Q4, Smith & Wesson generated an operating margin profit margin of 4.9%, up 3.1 percentage points year on year. This increase was a welcome development and shows it was more efficient.

Revenue trends explain a company’s historical growth, but the long-term change in earnings per share (EPS) points to the profitability of that growth – for example, a company could inflate its sales through excessive spending on advertising and promotions.

Sadly for Smith & Wesson, its EPS declined by 41.8% annually over the last five years, more than its revenue. This tells us the company struggled because its fixed cost base made it difficult to adjust to shrinking demand.

In Q4, Smith & Wesson reported adjusted EPS of $0.08, up from $0.02 in the same quarter last year. This print easily cleared analysts’ estimates, and shareholders should be content with the results. Over the next 12 months, Wall Street expects Smith & Wesson’s full-year EPS of $0.24 to grow 16.7%.

Free cash flow isn't a prominently featured metric in company financials and earnings releases, but we think it's telling because it accounts for all operating and capital expenses, making it tough to manipulate. Cash is king.

Smith & Wesson has shown poor cash profitability relative to peers over the last two years, giving the company fewer opportunities to return capital to shareholders. Its free cash flow margin averaged 3.1%, below what we’d expect for a consumer discretionary business.

Smith & Wesson’s free cash flow clocked in at $16.82 million in Q4, equivalent to a 12.4% margin. Its cash flow turned positive after being negative in the same quarter last year, but we wouldn’t read too much into the short term because investment needs can be seasonal, causing temporary swings. Long-term trends trump fluctuations.

EPS and free cash flow tell us whether a company was profitable while growing its revenue. But was it capital-efficient? A company’s ROIC explains this by showing how much operating profit it makes compared to the money it has raised (debt and equity).

Smith & Wesson historically did a mediocre job investing in profitable growth initiatives. Its four-year average ROIC was 10.4%, somewhat low compared to the best consumer discretionary companies that consistently pump out 25%+.

We like to invest in businesses with high returns, but the trend in a company’s ROIC is what often surprises the market and moves the stock price. Unfortunately, Smith & Wesson’s ROIC has decreased significantly over the last few years. Paired with its already low returns, these declines suggest its profitable growth opportunities are few and far between.

Smith & Wesson reported $23.46 million of cash and $106.7 million of debt on its balance sheet in the most recent quarter. As investors in high-quality companies, we primarily focus on two things: 1) that a company’s debt level isn’t too high and 2) that its interest payments are not excessively burdening the business.

With $64.16 million of EBITDA over the last 12 months, we view Smith & Wesson’s 1.3× net-debt-to-EBITDA ratio as safe. We also see its $4.86 million of annual interest expenses as appropriate. The company’s profits give it plenty of breathing room, allowing it to continue investing in growth initiatives.

It was good to see Smith & Wesson beat analysts’ EPS expectations this quarter. We were also excited its EBITDA outperformed Wall Street’s estimates by a wide margin. Zooming out, we think this quarter featured some important positives. The stock traded up 11.8% to $13.19 immediately after reporting.

Updated: March 5, 2026 at 4:13 PM EST

The latest quarterly earnings matters, sure, but we actually think longer-term fundamentals and valuation matter more. Investors should consider all these pieces before deciding whether or not to invest in Smith & Wesson.

Smith & Wesson falls short of our quality standards. On top of that, Smith & Wesson’s declining EPS over the last five years makes it a less attractive asset to the public markets, and its relatively low ROIC suggests management has struggled to find compelling investment opportunities.

Smith & Wesson’s P/E ratio based on the next 12 months is 42x. At this valuation, there’s a lot of good news priced in - you can find more timely opportunities elsewhere.

Wall Street analysts have a consensus one-year price target of $13.50 on the company (compared to the current share price of $13.19).